News | April 01, 2013

Loma Linda’s robotic positioning arm first in U.S. for patient’s use

April 1, 2013 — For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being used by Loma Linda University Medical Center (LLUMC) to provide physicians improved access to tumors typically regarded as difficult to reach and treat.

An increasingly attractive alternative to standard photon beam radiation (or IMRT), a proton beam more effectively pinpoints cancerous tumors while minimizing contact with surrounding healthy bone and tissue. The robotic positioning arm at LLUMC’s James M. Slater Proton Treatment and Research Center takes that effectiveness one step further by giving physicians improved access to reach tumors such as those in the liver, breast, prostate and lung.

The user-friendly, computer-controlled robotic arm in use at Loma Linda is the most advanced proton technology found anywhere in the world and combines the flexibility and accuracy needed for optimal treatment of a tumor. The robotic arm decreases the time needed to position a patient for proton treatments and verifies the location and dose of the prescribed treatment based on the patient’s individualized treatment plan. By assuring such accuracy and controlling the movement of the patient during treatment, the hospital is better able to precisely and safely target the tumor in a way that provides the correct therapeutic dose and avoids harm to healthy tissues surrounding the tumor.

“In addition to successfully treating the cancer itself, a patient’s comfort during treatment is of the utmost importance to us,” said Jerry D. Slater, M.D., chairman of the LLUMC center. “Not only does the robotic positioning arm allow proton beams to reach tumors more precisely, it’s also very comfortable for patients and helps alleviate some of the fears that traditionally accompany cancer treatment.”

Based on the expanded reach that the robotic positioning arm allows, physicians at LLUMC are now working on new clinical trials to study the effects of proton treatment on various types of tumors. According to Slater, “Since we have installed the robotic positioning arm, we have launched additional research studies such as our breast cancer trial to more closely examine the effects of treatment on tumors previously considered difficult to reach.”

For more information: www.lomalindahealth.org

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...